News
Verona Pharma, a year after receiving regulatory approval for its landmark chronic obstructive pulmonary disease (COPD) treatment, is being acquired by pharmaceutical giant Merck in a deal worth about ...
Charles E. Hamner Jr., a highly respected and accomplished scientist, university administrator and pharmaceutical executive who led the North Carolina Biotechnology Center during its formative years, ...
For the third time in four years, CNBC has ranked North Carolina as “America’s Top State for Business” in 2025.
Establishing strong international partnerships starts with clear expectations and well-structured agreements. Join EDPNC on July 16 for a 90-minute strategy session covering building productive and ...
Learn how Parker's filtration, fluid management, sensing technologies, and customized single-use solutions can:Improve final fill processesAddress Annex 1 requirementsImplement Pre-Use Post ...
ACI’s US Biostimulants Summit 2025 will bring together senior industry leaders, farmers, policymakers, and researchers to explore the growing world of biostimulants, aiming to redefine sustainable ...
Grifols, already the largest private employer in Johnston County, is about to get even bigger. The Spanish biotherapeutics company is investing $210 million in two new facilities at its manufacturing ...
NeuroTronik Inc. of Durham has closed on $23.1 million in Series B preferred stock financing to advance its therapy for treating acute heart failure in hospitals. The Durham-based venture capital firm ...
Novo Nordisk has officially begun building a $1.8 billion production facility for diabetes medicines at its Clayton site that will create 700 high-paying jobs, doubling its workforce there.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results